Each of these dystrophinopathies are characterised by either absent or reduced expression of the cytoskeletal protein dystrophin, resulting in progressive muscle degeneration with similar anatomical distribution but varied severity [2,3,4]. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.